Iranian
Biomedical Journal
Volume 26, Issue 4 (7-2022)
IBJ 2022, 26(4): 279-290 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shahnazari M, Bigdeli R, Dashbolaghi A, Ahangari Cohan R, Shoari A, Hosseini H, et al . Biochemical and Biological Evaluation of an L-Asparaginase from Isolated Escherichia coli MF-107 as an Anti-Tumor Enzyme on MCF7 Cell Line. IBJ 2022; 26 (4) :279-290
URL: http://ibj.pasteur.ac.ir/article-1-3494-en.html
URL: http://ibj.pasteur.ac.ir/article-1-3494-en.html
Masoumeh Shahnazari 
, Razieh Bigdeli , Aziz Dashbolaghi , Reza Ahangari Cohan , Alireza Shoari , Hossein Hosseini , Davoud Nouri Inanlou , Vahid Asgary *
, Razieh Bigdeli , Aziz Dashbolaghi , Reza Ahangari Cohan , Alireza Shoari , Hossein Hosseini , Davoud Nouri Inanlou , Vahid Asgary *
Abstract:
Background: One of the most widely used anticancer agents is microbial L-ASNase. Herein, we assessed the biochemical and biological properties of an isolated L-ASNase from a Gram-negative bacteria strain, Escherichia coli MF-107.
Methods: Using garden asparagus, we obtained several bacterial isolates. These strains were further screened for L-ASNase activity. A promising bacterial isolate was selected for L-ASNase production and subsequent purification. The molecular weight of purified L-ASNase was determined. The MTT assay was applied to assess the cytotoxic effect of the purified enzyme. Also, for caspase activity determination and the apoptotic effect of purified enzyme on in cells, we conducted a real-time PCR method.
Results: The molecular weight of the enzyme was approximately 37 kDa. In the pH range of 7.5 to 8, the enzyme had considerable stability. At 35 °C, the purified L-ASNase optimum activity was recorded. The cytotoxic effect of the enzyme on treated cells was dose-dependent with an IC50 value of 5.7 IU/ml. The Bax gene expression considerably raised by 5.75-fold (p < 0.001) upon L-ASNase treatment. On the other hand, the anti-apoptotic Bcl-2 gene expression showed a 2.63-fold increase compared to the control (p < 0.05). It was detected that the mRNA levels of caspase-3 and p53 were considerably upregulated (5.93 and 1.85-fold, respectively). We did not find any alternation in the caspase-8 activity of the treated cells compared to untreated cells.
Conclusion: In this research, the proliferation of the breast cancer cells remarkably inhibited via the cytotoxic effect of isolated L-ASNase from microbial sources.
Methods: Using garden asparagus, we obtained several bacterial isolates. These strains were further screened for L-ASNase activity. A promising bacterial isolate was selected for L-ASNase production and subsequent purification. The molecular weight of purified L-ASNase was determined. The MTT assay was applied to assess the cytotoxic effect of the purified enzyme. Also, for caspase activity determination and the apoptotic effect of purified enzyme on in cells, we conducted a real-time PCR method.
Results: The molecular weight of the enzyme was approximately 37 kDa. In the pH range of 7.5 to 8, the enzyme had considerable stability. At 35 °C, the purified L-ASNase optimum activity was recorded. The cytotoxic effect of the enzyme on treated cells was dose-dependent with an IC50 value of 5.7 IU/ml. The Bax gene expression considerably raised by 5.75-fold (p < 0.001) upon L-ASNase treatment. On the other hand, the anti-apoptotic Bcl-2 gene expression showed a 2.63-fold increase compared to the control (p < 0.05). It was detected that the mRNA levels of caspase-3 and p53 were considerably upregulated (5.93 and 1.85-fold, respectively). We did not find any alternation in the caspase-8 activity of the treated cells compared to untreated cells.
Conclusion: In this research, the proliferation of the breast cancer cells remarkably inhibited via the cytotoxic effect of isolated L-ASNase from microbial sources.
Type of Study: Full Length/Original Article |
Subject:
Pharmaceutical Biotechnology
References
1. Brumano LP, da Silva FVS, Costa-Silva TA, Apolinário AC, Santos JHPM, Kleingesinds EK, Monteiro G, Rangel-Yagui C de O, Benyahia B, Junior AP. Development of L-asparaginase biobetters: current research status and review of the desirable quality profiles. Frontiers in bioengineering and biotechnology 2019; 6: 212. [DOI:10.3389/fbioe.2018.00212]
2. Cachumba JJM, Antunes FAF, Peres GFD, Brumano LP, Santos JC Dos, Da Silva SS. Current applications and different approaches for microbial L-asparaginase production. Brazilian journal of microbiology 2016; 47(Suppl 1): 77-85. [DOI:10.1016/j.bjm.2016.10.004]
3. Piatkowska-Jakubas B, Krawczyk-Kuliś M, Giebel S, Adamczyk-Cioch M, Czyz A, Lech ME, Paluszewska M, Pałynyczko G, Piszcz J, Hołowiecki J. Use of L-asparaginase in acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group. Polskie archiwum medycyny wewnętrznej 2008; 118(11): 664-669. [DOI:10.20452/pamw.518]
4. Nunes JCF, Cristóvão RO, Freire MG, Santos-Ebinuma VC, Faria JL, Silva CG, Tavares APM. Recent strategies and applications for l-Asparaginase confinement. Molecules (Basel, Switzerland) 2020; 25(24): 5827. [DOI:10.3390/molecules25245827]
5. Savitri, Asthana N, Azmi W. Microbial L-asparaginase: A potent antitumour enzyme. Indian journal of biotechnology 2003; 2(2): 184-194.
6. Knott SR V, Wagenblast E, Khan S, Kim SY, Soto M, Wagner M, Turgeon MO, Fish L, Erard N, Gable AL. Asparagine bioavailability governs metastasis in a model of breast cancer. Nature 2018; 554(7692): 378-381. [DOI:10.1038/nature25465]
7. Zhang J, Fan J, Venneti S, Cross JR, Takagi T, Bhinder B, Djaballah H, Kanai M, Cheng EH, Judkins AR. Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion. Molecular cell 2014; 56(2): 205-218. [DOI:10.1016/j.molcel.2014.08.018]
8. Hettmer S, Schinzel AC, Tchessalova D, Schneider M, Parker CL, Bronson RT, Richards NGJ, Hahn WC, Wagers AJ. Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma. Elife 2015; 4: e09436. [DOI:10.7554/eLife.09436]
9. Xu Y, Lv F, Zhu X, Wu Y, Shen X. Loss of asparagine synthetase suppresses the growth of human lung cancer cells by arresting cell cycle at G0/G1 phase. Cancer gene therapy 2016; 23(2): 287-294. [DOI:10.1038/cgt.2016.28]
10. Yang H, He X, Zheng Y, Feng W, Xia X, Yu X, Lin Z. Down‐regulation of asparagine synthetase induces cell cycle arrest and inhibits cell proliferation of breast cancer. Chemical biology and drug design 2014; 84(5): 578-584. [DOI:10.1111/cbdd.12348]
11. Sircar K, Huang H, Hu L, Cogdell D, Dhillon J, Tzelepi V, Efstathiou E, Koumakpayi IH, Saad F, Luo D. Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer. The American journal of pathology 2012; 180(3): 895-903. [DOI:10.1016/j.ajpath.2011.11.030]
12. Krall AS, Xu S, Graeber TG, Braas D, Christofk HR. Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor. Nature communications 2016; 7: 1-13. [DOI:10.1038/ncomms11457]
13. Richards NGJ, Kilberg MS. Asparagine synthetase chemotherapy. Annual review of biochemistry 2006; 75: 629-654. [DOI:10.1146/annurev.biochem.75.103004.142520]
14. Baskar G, Lalitha K, Aiswarya R, Naveenkumar R. Synthesis, characterization and synergistic activity of cerium-selenium nanobiocomposite of fungal l-asparaginase against lung cancer. Materials science and engineering: c 2018; 93: 809-815. [DOI:10.1016/j.msec.2018.08.051]
15. Baskar G, Sree NS. Anticancer activity of gelatin-asparaginase nanobiocomposite against cervical and brain cancer cell lines. Journal of drug delivery science and technology 2020; 57: 101689. [DOI:10.1016/j.jddst.2020.101689]
16. Baskar G, Sree NS. Synthesis, characterization and anticancer activity of β-cyclodextrin-Asparaginase nanobiocomposite on prostate and lymphoma cancer cells. Journal of drug delivery science and technology 2020; 55: 101417. [DOI:10.1016/j.jddst.2019.101417]
17. El-Naggar NE-A, Deraz SF, Soliman HM, El-Deeb NM, El-Ewasy SM. Purification, characterization, cytotoxicity and anticancer activities of L-asparaginase, anti-colon cancer protein, from the newly isolated alkaliphilic Streptomyces fradiae NEAE-82. Scientific reports 2016; 6: 32926. [DOI:10.1038/srep32926]
18. Sugimoto K, Suzuki HI, Fujimura T, Ono A, Kaga N, Isobe Y, Sasaki M, Taka H, Miyazono K, Komatsu N. A clinically attainable dose of L‐asparaginase targets glutamine addiction in lymphoid cell lines. Cancer science 2015; 106(11): 1534-1543. [DOI:10.1111/cas.12807]
19. Andrade AF, Borges KS, Silveira VS. Update on the use of L-asparaginase in infants and adolescent patients with acute lymphoblastic leukemia. Clinical Medicine Insights. Oncology 2014; 8: CMO-S10242. [DOI:10.4137/CMO.S10242]
20. Aghaeepoor M, Akbarzadeh A, Mirzaie S, Hadian A, Aval SJ, Dehnavi E. Selective reduction in glutaminase activity of l‑Asparaginase by asparagine 248 to serine mutation: A combined computational and experimental effort in blood cancer treatment. International journal of biological macromolecules 2018; 120: 2448-2457. [DOI:10.1016/j.ijbiomac.2018.09.015]
21. Nguyen HA, Su Y, Zhang JY, Antanasijevic A, Caffrey M, Schalk AM, Liu L, Rondelli D, Oh A, Mahmud DL, Bosland MC, Kajdacsy-Balla A, Peirs S, Lammens T, Mondelaers V, De Moerloose B, Goossens S, Schlicht MJ, Kabirov KK, Lyubimov A V., Merrill BJ, Saunthararajah Y, Van Vlierberghe P, Lavie A. A novel L-asparaginase with low L-glutaminase coactivity is highly efficacious against both T- and B-cell acute lymphoblastic Leukemias In Vivo. Cancer research 2018; 78(6): 1549-1560. [DOI:10.1158/0008-5472.CAN-17-2106]
22. Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P, Benoit Y, Robert A, Manel AM, Vilmer E, Otten J, Philippe N. Comparison of escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: Results of a randomized European Organisation for research and treatment of cancer-children's Leukemia group phase 3 trial. Blood 2002; 99: 2734-2739. [DOI:10.1182/blood.V99.8.2734]
23. Mashinchian O, Johari-Ahar M, Ghaemi B, Rashidi M, Barar J, Omidi Y. Impacts of quantum dots in molecular detection and bioimaging of cancer. BioImpacts: BI 2014; 4(3): 149. [DOI:10.15171/bi.2014.008]
24. Sushma C, Anand AP, Veeranki VD. Enhanced production of glutaminase free L-asparaginase II by Bacillus subtilis WB800N through media optimization. Korean journal chemical engineering 2017; 34: 2901-2915. [DOI:10.1007/s11814-017-0211-1]
25. Farag AM, Hassan SW, Beltagy EA, El-Shenawy MA. Optimization of production of anti-tumor l-asparaginase by free and immobilized marine Aspergillus terreus. The egyptian journal of aquatic research 2015; 41(4): 295-302. [DOI:10.1016/j.ejar.2015.10.002]
26. Mahajan R V, Saran S, Saxena RK, Srivastava AK. A rapid, efficient and sensitive plate assay for detection and screening of l-asparaginase-producing micro-organisms. FEMS microbiology letters 2013; 341(2): 122-126. [DOI:10.1111/1574-6968.12100]
27. Imada A, Igarasi S, Nakahama K, Isono M. Asparaginase and glutaminase activities of micro organisms. Journal of general microbiology 1973; 76(1): 85-99. [DOI:10.1099/00221287-76-1-85]
28. Alrumman SA, Mostafa YS, Al-Izran KA, Alfaifi MY, Taha TH, Elbehairi SE. Production and anticancer activity of an L-asparaginase from Bacillus licheniformis isolated from the Red Sea, Saudi Arabia. Scientific reports 2019; 9: 1-14. [DOI:10.1038/s41598-019-40512-x]
29. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical biochemistry 1976; 72: 248-254. [DOI:10.1016/0003-2697(76)90527-3]
30. Distasio JA, Niederman RA, Kafkewitz D, Goodman D. Purification and characterization of L-asparaginase with anti-lymphoma activity from Vibrio succinogenes. The journal of biological chemistry 1976; 251(22): 6929-6933. [DOI:10.1016/S0021-9258(17)32924-1]
31. Gholami N, Cohan RA, Razavi A, Bigdeli R, Dashbolaghi A, Asgary V. Cytotoxic and apoptotic properties of a novel nano‐toxin formulation based on biologically synthesized silver nanoparticle loaded with recombinant truncated pseudomonas exotoxin A. Journal of cellular physiology 2020; 235(4): 3711-3720. [DOI:10.1002/jcp.29265]
32. Ghasemi A, Asad S, Kabiri M, Dabirmanesh B. Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent. Applied microbiology and biotechnology 2017; 101(19): 7227-7238. [DOI:10.1007/s00253-017-8456-5]
33. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the national cancer institute 1990; 82(13): 1107-1112. [DOI:10.1093/jnci/82.13.1107]
34. Golbabaie A, Nouri H, Moghimi H, Khaleghian A. l‐asparaginase production and enhancement by Sarocladium strictum: In vitro evaluation of anti‐cancerous properties. Journal of applied microbiology 2020; 129(2): 356-366. [DOI:10.1111/jam.14623]
35. Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell metabolism 2016; 23(1): 27-47. [DOI:10.1016/j.cmet.2015.12.006]
36. Lukey MJ, Katt WP, Cerione RA. Targeting amino acid metabolism for cancer therapy. Drug discovery today 2017; 22(5): 796-804. [DOI:10.1016/j.drudis.2016.12.003]
37. Kim K, Jeong JH, Lim D, Hong Y, Lim HJ, Kim GJ, Shin SR, Lee JJ, Yun M, Harris RA, Min JJ, Choy HE. L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors. Molecular therapy oncolytics 2015; 2: 15007. [DOI:10.1038/mto.2015.7]
38. Chan WK, Lorenzi PL, Anishkin A, Purwaha P, Rogers DM, Sukharev S, Rempe SB, Weinstein JN. The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells. Blood 2014; 123(23): 3596-3606. [DOI:10.1182/blood-2013-10-535112]
39. Kebeish R, El-Sayed A, Fahmy H, Abdel-Ghany A. Molecular cloning, biochemical characterization, and antitumor properties of a novel L-asparaginase from Synechococcus elongatus PCC6803. Biochemistry biokhimii︠a︡ 2016; 81(10): 1173-1181. [DOI:10.1134/S000629791610014X]
40. Covini D, Tardito S, Bussolati O, R Chiarelli L, V Pasquetto M, Digilio R, Valentini G, Scotti C. Expanding targets for a metabolic therapy of cancer: L-asparaginase. Recent patents on anti-cancer drug discovery 2012; 7(1): 4-13. [DOI:10.2174/157489212798358001]
41. Mangamuri U, Muvva V, Poda S. Purification and characterization of L-asparaginase by Pseudonocardia endophytic VUK-10 isolated from Nizampatnam mangrove ecosystem. International journal of pharmacy and pharmaceutical sciences 2016; 8: 281-285.
42. Radha R, Arumugam N, Gummadi SN. Glutaminase free L-asparaginase from Vibrio cholerae: heterologous expression, purification and biochemical characterization. International journal of biological macromolecules 2018; 111: 129-138. [DOI:10.1016/j.ijbiomac.2017.12.165]
43. Cachumba JJM, Antunes FAF, Peres GFD, Brumano LP, Dos Santos JC, Da Silva SS. Current applications and different approaches for microbial L-asparaginase production. Brazilian journal of microbiology 2016; 47(1): 77-85. [DOI:10.1016/j.bjm.2016.10.004]
44. Castro D, Marques ASC, Almeida MR, de Paiva GB, Bento HBS, Pedrolli DB, Freire MG, Tavares APM, Santos-Ebinuma VC. L-asparaginase production review: bioprocess design and biochemical characteristics. Applied microbiology and biotechnology 2021; 105(11): 1-20. [DOI:10.1007/s00253-021-11359-y]
45. Chand S, Mahajan R V, Prasad JP, Sahoo DK, Mihooliya KN, Dhar MS, Sharma G. A comprehensive review on microbial l‐asparaginase: Bioprocessing, characterization, and industrial applications. Biotechnology and applied biochemistry 2020; 67(4): 619-647. [DOI:10.1002/bab.1888]
46. Arjun JK, Aneesh B, Kavitha T, Hari Krishnan K. Therapeutic L-asparaginase activity of bacteria isolated from marine sediments. Biotechnology and applied biochemistry 2016; 8(4): 229-234. [DOI:10.25004/IJPSDR.2016.080407]
47. Moharam ME, Gamal-Eldeen AM, El-Sayed ST. Production, immobilization and anti-tumor activity of L-asparaginase of Bacillus sp R36. Journal of American science 2010; 6: 131-140.
48. Shafei MS, El-Refai HA, Mostafa H, El-Refai A-MH, El-Beih FM, Easa SM, Gomaa SK. Purification, characterization and kinetic properties of Penicillium cyclopium L-asparaginase: Impact of L-asparaginase on acrylamide content in potato products and its cytotoxic activity. Current trends in biotechnology and pharmacy 2015; 9(2): 132-140.
49. Cooper AJL, Shurubor YI, Dorai T, Pinto JT, Isakova EP, Deryabina YI, Denton TT, Krasnikov BF. ω-Amidase: An underappreciated, but important enzyme in L-glutamine and L-asparagine metabolism; relevance to sulfur and nitrogen metabolism, tumor biology and hyperammonemic diseases. Amino acids 2016; 48(1): 1-20. [DOI:10.1007/s00726-015-2061-7]
50. Hashimoto K, Suzuki F, Sakagami H. Declined asparagine synthetase mRNA expression and enhanced sensitivity to asparaginase in HL-60 cells committed to monocytic differentiation. Anticancer research 2009; 29(4): 1303-1308.
51. Karpel-Massler G, Ramani D, Shu C, Halatsch M-E, Westhoff M-A, Bruce JN, Canoll P, Siegelin MD. Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivo. Oncotarget 2016; 7(23): 33512. [DOI:10.18632/oncotarget.9257]
52. Muñoz-Pinedo C, El Mjiyad N, Ricci JE. Cancer metabolism: current perspectives and future directions. Cell death and disease 2012; 3(1): e248-e248. [DOI:10.1038/cddis.2011.123]
53. Ueno T, Ohtawa K, Mitsui K, Kodera Y, Hiroto M, Matsushima A, Inada Y, Nishimura H. Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase. Leukemia 1997; 11(11): 1858-1861. [DOI:10.1038/sj.leu.2400834]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |